Biopharma Industry Review: A Year of Challenges and Changes in 2023 The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number … Continue ›››
From Diagnosis to Treatment: The Impact of AI on Rare Disease Drug Development Drug development for rare (also referred to as orphan) diseases is notoriously challenging. Legislative initiatives, such as the 1983 US … Continue ›››